Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method

Area of Science:

• Nuclear Medicine
• Pharmacology
• Cardiovascular Science

Background:

• Myocardial beta-adrenergic receptors play a crucial role in cardiac function and are targets for various cardiovascular drugs.
• Accurate in vivo quantification of these receptors is essential for understanding cardiac physiology and disease.
• Previous kinetic methods for receptor quantification were limited by metabolite interference.

Purpose of the Study:

• To develop and validate a novel graphical method for in vivo quantification of myocardial beta-adrenergic receptors using positron emission tomography (PET).
• To overcome the limitations of kinetic modeling in receptor imaging due to metabolite presence.
• To accurately determine receptor density (Bmax) and dissociation rate constant (kd) in canine myocardium.

Main Methods:

• Utilized positron emission tomography (PET) in five closed-chest dogs.
• Employed a novel graphical analysis protocol with sequential injections of racemic (+/-)[11C] CGP 12177 (a beta-adrenergic receptor antagonist).
• Involved a trace dose, followed by a low-specific activity dose, and then an excess of unlabeled tracer to estimate kinetic parameters.

Main Results:

• The developed graphical method successfully quantified myocardial beta-adrenergic receptors.
• The average maximal receptor density (Bmax) was determined to be 31 +/- 4 pmol/ml of tissue.
• The dissociation rate constant (kd) was estimated at 0.014 +/- 0.002 min-1.

Conclusions:

• The proposed graphical method offers a robust alternative for in vivo quantification of myocardial beta-adrenergic receptors.
• This approach eliminates the need for input function measurement and metabolite analysis, simplifying the quantification process.
• The findings provide valuable data on beta-adrenergic receptor density in canine myocardium, relevant for cardiovascular research.